BLOZF
Price
$0.23
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
CBSC
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Dec 19 closing price
Ad is loading...

BLOZF vs CBSC

Header iconBLOZF vs CBSC Comparison
Open Charts BLOZF vs CBSCBanner chart's image
Cannabix Technologies
Price$0.23
Change-$0.00 (-0.00%)
Volume$111.47K
CapitalizationN/A
CB Scientific
Price$0.06
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
BLOZF vs CBSC Comparison Chart
Loading...
BLOZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLOZF vs. CBSC commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLOZF is a Hold and CBSC is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BLOZF: $0.23 vs. CBSC: $0.06)
Brand notoriety: BLOZF and CBSC are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLOZF: 136% vs. CBSC: 2%
Market capitalization -- BLOZF: $22.39M vs. CBSC: $21.25M
BLOZF [@Medical Specialties] is valued at $22.39M. CBSC’s [@Medical Specialties] market capitalization is $21.25M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLOZF’s FA Score shows that 0 FA rating(s) are green whileCBSC’s FA Score has 1 green FA rating(s).

  • BLOZF’s FA Score: 0 green, 5 red.
  • CBSC’s FA Score: 1 green, 4 red.
According to our system of comparison, CBSC is a better buy in the long-term than BLOZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLOZF’s TA Score shows that 4 TA indicator(s) are bullish while CBSC’s TA Score has 5 bullish TA indicator(s).

  • BLOZF’s TA Score: 4 bullish, 5 bearish.
  • CBSC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CBSC is a better buy in the short-term than BLOZF.

Price Growth

BLOZF (@Medical Specialties) experienced а -3.50% price change this week, while CBSC (@Medical Specialties) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLOZF($22.4M) has a higher market cap than CBSC($21.3M). BLOZF YTD gains are higher at: 78.815 vs. CBSC (-41.000). CBSC has higher annual earnings (EBITDA): -2.29M vs. BLOZF (-2.53M). BLOZF has more cash in the bank: 6.94M vs. CBSC (8.53K). CBSC has higher revenues than BLOZF: CBSC (131K) vs BLOZF (0).
BLOZFCBSCBLOZF / CBSC
Capitalization22.4M21.3M105%
EBITDA-2.53M-2.29M110%
Gain YTD78.815-41.000-192%
P/E RatioN/AN/A-
Revenue0131K-
Total Cash6.94M8.53K81,400%
Total DebtN/A100K-
FUNDAMENTALS RATINGS
BLOZF vs CBSC: Fundamental Ratings
BLOZF
CBSC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6438
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLOZF's Valuation (52) in the null industry is somewhat better than the same rating for CBSC (100). This means that BLOZF’s stock grew somewhat faster than CBSC’s over the last 12 months.

CBSC's Profit vs Risk Rating (97) in the null industry is in the same range as BLOZF (100). This means that CBSC’s stock grew similarly to BLOZF’s over the last 12 months.

BLOZF's SMR Rating (96) in the null industry is in the same range as CBSC (100). This means that BLOZF’s stock grew similarly to CBSC’s over the last 12 months.

CBSC's Price Growth Rating (38) in the null industry is in the same range as BLOZF (64). This means that CBSC’s stock grew similarly to BLOZF’s over the last 12 months.

CBSC's P/E Growth Rating (3) in the null industry is significantly better than the same rating for BLOZF (100). This means that CBSC’s stock grew significantly faster than BLOZF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLOZFCBSC
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
BLOZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MLPX59.601.13
+1.93%
Global X MLP & Energy Infrastructure ETF
XRLV53.240.48
+0.90%
Invesco S&P 500® ex-Rate Snsv LowVol ETF
BJUN41.590.27
+0.66%
Innovator U.S. Equity Buffer ETF™ - June
ILIT8.980.04
+0.50%
iShares Lithium Miners And Producers ETF
GXUS45.37N/A
N/A
Goldman Sachs MarketBeta(R) Ttl IntEqETF

BLOZF and

Correlation & Price change

A.I.dvisor tells us that BLOZF and PXMBF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLOZF and PXMBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLOZF
1D Price
Change %
BLOZF100%
+1.07%
PXMBF - BLOZF
24%
Poorly correlated
N/A
NUWE - BLOZF
22%
Poorly correlated
-0.99%
ANPCF - BLOZF
21%
Poorly correlated
N/A
BRSYF - BLOZF
4%
Poorly correlated
N/A
BBLG - BLOZF
4%
Poorly correlated
-3.81%
More

CBSC and

Correlation & Price change

A.I.dvisor tells us that CBSC and QTI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBSC and QTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBSC
1D Price
Change %
CBSC100%
N/A
QTI - CBSC
21%
Poorly correlated
+8.56%
LNSR - CBSC
20%
Poorly correlated
+2.67%
CALZF - CBSC
6%
Poorly correlated
N/A
BBLG - CBSC
3%
Poorly correlated
-3.81%
BLOZF - CBSC
3%
Poorly correlated
+1.07%
More